SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001140361-12-019887
Filing Date
2012-04-10
Accepted
2012-04-10 13:39:32
Documents
2
Group Members
CITIGROUP FINANCIAL PRODUCTS INCCITIGROUP GLOBAL MARKETS HOLDINGS INCCITIGROUP GLOBAL MARKETS INC

Document Format Files

Seq Description Document Type Size
1 ENZON PHARMACEUTICALS SC 13GA 3-31-2012 formsc13ga.txt SC 13G/A 19104
2 EXHIBIT 99.1 ex99_1.txt EX-99.1 1600
  Complete submission text file 0001140361-12-019887.txt   22998
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-35587 | Film No.: 12751546
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 399 PARK AVENUE NEW YORK NY 10043
Business Address 399 PARK AVENUE NEW YORK NY 10043 2125591000
CITIGROUP INC (Filed by) CIK: 0000831001 (see all company filings)

IRS No.: 521568099 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks